Clinical Trial

Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)

Name: Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT) — clinical trial record (NCT07718633)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IMPAKT

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

IMPAKT is a research study that looks at whether a blood test called Prospera™ can help doctors better adjust anti-rejection medications, compared to the usual way doctors manage these medications without using this test.

Trial Details

NCT Number	NCT07718633
Lead Sponsor	Natera, Inc.
Conditions	Kidney Transplant, Immunosuppresion
Enrollment	750 participants
Start Date	2026-07
Primary Completion	2027-12 (estimated)
Study Completion	2031-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-22